BE885255A - Composes de 10-deazaminopterine, leur preparation et leur utilisation - Google Patents

Composes de 10-deazaminopterine, leur preparation et leur utilisation

Info

Publication number
BE885255A
BE885255A BE0/202121A BE202121A BE885255A BE 885255 A BE885255 A BE 885255A BE 0/202121 A BE0/202121 A BE 0/202121A BE 202121 A BE202121 A BE 202121A BE 885255 A BE885255 A BE 885255A
Authority
BE
Belgium
Prior art keywords
preparation
deazaminopterin
compounds
deazaminopterin compounds
Prior art date
Application number
BE0/202121A
Other languages
English (en)
Inventor
J Graw
F Sirotnak
Original Assignee
Stanford Res Inst Int
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int, Sloan Kettering Inst Cancer filed Critical Stanford Res Inst Int
Publication of BE885255A publication Critical patent/BE885255A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
BE0/202121A 1979-09-17 1980-09-16 Composes de 10-deazaminopterine, leur preparation et leur utilisation BE885255A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/075,913 US4393064A (en) 1976-03-05 1979-09-17 Process and composition for treatment of leukemia and process for preparing the same
US06/233,280 US4369319A (en) 1979-09-17 1981-02-10 10-Alkyl-10-deazaminopterins
US06/344,564 US4433147A (en) 1979-09-17 1982-01-22 Process for preparing 10-deazaminopterins

Publications (1)

Publication Number Publication Date
BE885255A true BE885255A (fr) 1981-01-16

Family

ID=27372768

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/202121A BE885255A (fr) 1979-09-17 1980-09-16 Composes de 10-deazaminopterine, leur preparation et leur utilisation

Country Status (9)

Country Link
US (3) US4393064A (fr)
JP (2) JPS5651482A (fr)
AU (1) AU540326B2 (fr)
BE (1) BE885255A (fr)
CA (1) CA1139752A (fr)
DE (1) DE3034843A1 (fr)
FR (2) FR2464956A1 (fr)
GB (1) GB2058770B (fr)
ZA (1) ZA805474B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140104A (en) * 1982-03-09 1992-08-18 Cytogen Corporation Amine derivatives of folic acid analogs
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
JPS6237911A (ja) * 1985-08-12 1987-02-18 Sumitomo Special Metals Co Ltd 異方性フエライト磁石
US4746659A (en) * 1985-12-30 1988-05-24 Sri International Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
JPS62281878A (ja) * 1986-02-26 1987-12-07 Taisho Pharmaceut Co Ltd アザアントラセン化合物
US4833145A (en) * 1986-06-30 1989-05-23 The Trustees Of Princeton University 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US4940713A (en) * 1988-04-15 1990-07-10 Burroughs Wellcome Co. Substituted glutamic acids
US5019577A (en) * 1988-04-15 1991-05-28 Burroughs Welcome Co. Novel compounds and use
FR2640638B1 (fr) * 1988-12-20 1991-02-15 Commissariat Energie Atomique Bioreacteur et dispositif pour la culture de cellules animales
JPH03118740A (ja) * 1989-09-29 1991-05-21 Hitachi Metals Ltd アークセグメント磁石
US5028608A (en) * 1989-12-11 1991-07-02 The Trustees Of Princeton University N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
US5073554A (en) * 1990-01-18 1991-12-17 Nair Madhavan G Two non-polyglutamatable antifolates
US5030634A (en) * 1990-03-29 1991-07-09 Krumdieck Carlos L 10-deazaaminopterin: a new arthritis remittive drug
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
US5159079A (en) * 1991-12-20 1992-10-27 Eli Lilly And Company 2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids
US5374726A (en) * 1992-03-03 1994-12-20 Degraw; Joseph I. Process for preparing 10-deazaaminopterins and 5,10-and 8,10-dideazaaminopterins from pteroic dicarboxylic acid diesters
US5354751A (en) * 1992-03-03 1994-10-11 Sri International Heteroaroyl 10-deazaamino-pterine compounds and use for rheumatoid arthritis
WO1993022315A1 (fr) * 1992-04-29 1993-11-11 Sri International Heteroaroyl-10-desazaaminopterines pour le traitement des inflammations
US5260296A (en) * 1992-05-13 1993-11-09 Nair Madhavan G Thiophene substituted antitumor antifolates
US5534514A (en) * 1992-10-27 1996-07-09 San Diego State University Anti-neoplastic compositions and methods for application thereof
US5550128A (en) * 1994-09-09 1996-08-27 Nair; Madhavan G. Enantiomers of gamma methylene 10-deaza aminopterin and process for preparing the same
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
DK0944389T3 (da) * 1996-07-17 2008-11-17 Sloan Kettering Inst Cancer Oprensede sammensætninger af 10-propargyl-10-deazaaminopterin og fremgangsmåder til anvendelse deraf i behandlingen af tumorer
WO1998024789A1 (fr) * 1996-12-02 1998-06-11 Bionumerik Pharmaceuticals, Inc. PROCEDE DE PRODUCTION DE η-METHYLENE-10-DEAZAAMINOPTERINE (MDAM)
WO2000039129A1 (fr) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Effets immunosuppresseurs de derives de la pteridine
BR0306861A (pt) 2002-01-14 2004-11-03 Novartis Ag Combinações que compreendem epotilonas e antimetabólitos
US20040092739A1 (en) * 2002-11-13 2004-05-13 Zejun Xiao Process for synthesizing antifolates
AU2005249516B2 (en) * 2004-05-30 2010-11-18 Sloan-Kettering Institute For Cancer Research Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
US20080188479A1 (en) * 2004-05-30 2008-08-07 Sloan-Kettering Institute For Cancer Research Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin
US8263354B2 (en) * 2004-05-30 2012-09-11 Sloan-Kettering Institute For Cancer Research Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin
US9901578B2 (en) 2007-08-17 2018-02-27 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20090048262A1 (en) * 2007-08-17 2009-02-19 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20100248249A1 (en) * 2007-08-17 2010-09-30 Allos Therapeutics, Inc. Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
WO2011096947A1 (fr) 2010-02-02 2011-08-11 Allos Therapeutics, Inc. Diastéréo-isomères optiquement purs de 10-propargyl-10-deazaaminoptérine, et leurs procédés d'utilisation
CN103274943B (zh) * 2013-05-24 2015-01-21 苏州明锐医药科技有限公司 4-[1-(2-丙炔基)-3,4-二氧代正丁基]苯甲酸酯及其制备方法
CN103265544B (zh) * 2013-05-27 2015-05-20 苏州明锐医药科技有限公司 普拉曲沙的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2709506A1 (de) * 1976-03-05 1977-09-08 Stanford Research Inst Arzneimittel, enthaltend 10-deazaminopterin
US4172200A (en) * 1978-06-15 1979-10-23 Southern Research Institute Process for the preparation of 10-deazaaminopterin and related compounds

Also Published As

Publication number Publication date
CA1139752A (fr) 1983-01-18
JPH034553B2 (fr) 1991-01-23
AU6243980A (en) 1981-03-26
DE3034843C2 (fr) 1989-10-05
US4369319A (en) 1983-01-18
ZA805474B (en) 1981-08-26
FR2464956B1 (fr) 1983-04-29
JPH0334979A (ja) 1991-02-14
FR2464956A1 (fr) 1981-03-20
DE3034843A1 (de) 1981-06-11
FR2477152A1 (fr) 1981-09-04
FR2477152B1 (fr) 1983-03-11
GB2058770B (en) 1983-05-25
US4393064A (en) 1983-07-12
AU540326B2 (en) 1984-11-15
JPS5651482A (en) 1981-05-09
US4433147A (en) 1984-02-21
JPH0340029B2 (fr) 1991-06-17
GB2058770A (en) 1981-04-15

Similar Documents

Publication Publication Date Title
BE885255A (fr) Composes de 10-deazaminopterine, leur preparation et leur utilisation
BE884300A (fr) Amides, leur preparation et leur utilisation
BE879586A (fr) Phosphinylalcanoyl prolines, leur preparation et leur utilisation
BE879528A (fr) Derives de 1-piperazine-carboxamides et -carbothioamides substitues, leur preparation et leur utilisation
LU80886A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes,et leur utilisation therapeutique
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE889401A (fr) 10-alcynyl steroides, leur preparation et leur utilisation
FR2494689B1 (fr) Xanthates, leur preparation et leur utilisation
FR2470134B1 (fr) Nouveaux antibiotiques, leur preparation et leur utilisation
BE871807A (fr) 4-quinolyl-guanidines, leur preparation et leur utilisation
BE870196A (fr) Colorants, leur preparation et leur utilisation
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE838833A (fr) Composes 3-acyloxymethyl-cephemes, leur preparation et leur utilisation
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE884286A (fr) Acylurees, leur procede de preparation et leur utilisation
BE882010A (fr) Tetrahydrobenzothiazolylimidazolidinones et leur utilisation
BE868953A (fr) Peptides, leur preparation et leur utilisation
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
BE861351A (fr) Composes alcanoylanilides et leur preparation
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
BE879729A (fr) Composes azotes ortho-condenses tricycliques, leur preparation et leur utilisation
BE888608A (fr) Esters de steroide-oxazoles, leur preparation et leur utilisation,
BE882104R (fr) Alpha-halogenomethylamines, leur preparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SRI INTERNATIONAL

Effective date: 19980930

Owner name: SLOAN KETTERING INSTITUTE FOR CANCERRESEARCH

Effective date: 19980930